Bleichroeder LP - Significant Ownership

Signature - Title
/s/ Andrew Gundlach - Andrew Gundlach, Chairman and CEO
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Bleichroeder LP.

Significant Ownership of Bleichroeder LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
First Eagle Real Estate Debt Fund Class I Common Shares of Beneficial Interest, $0.001 par value 99% 1.37M +86.2% Bleichroeder LP Aug 6, 2025
LIQT LiqTech International, Inc. Common Stock, $0.001 par value 33.7% $1.3M 3.18M 0% Bleichroeder LP Mar 26, 2025
SCND Scientific Industries, Inc. Common Stock, $0.05 par value 22.69% $3.08M $520K 2.97M +20.3% Bleichroeder LP Apr 18, 2025
DUOT Duos Technologies Group, Inc. Common Shares 19.99% $8.49M 1.5M Bleichroeder LP Mar 19, 2025
INVE Identiv, Inc. (INVE) Common Stock, $0.001 par value 19.9% $15.5M 5.08M Bleichroeder LP Mar 19, 2025
IVAC Intevac, Inc. Common Shares 19.11% $20.1M 5.04M Bleichroeder LP Mar 19, 2025
MDXH MDxHealth SA Ordinary Shares 15% $24.2M 7.43M +0.69% Bleichroeder LP Mar 19, 2025
IDN Intellicheck, Inc. Common Shares 11.06% $6.28M 2.07M Bleichroeder LP Mar 19, 2025
CUE Cue Biopharma, Inc. Common Stock, par value $0.001 per share 9.99% $4.17M 6.13M 0% Bleichroeder LP Mar 19, 2025
EVOK Evoke Pharma, Inc. Common Shares 9.99% $63.2K 158K -81.4% Bleichroeder LP Mar 24, 2025
CRIS Curis Inc Common Shares 9.9% $1.51M 1.04M Bleichroeder LP Mar 31, 2025
DTIL PRECISION BIOSCIENCES INC Common Shares 9.69% $5.1M 1.08M Bleichroeder LP Jun 30, 2025
BRFH Barfresh Food Group Inc. Common Shares 8.8% $3.85M $656K 1.39M +20.5% Bleichroeder LP Mar 24, 2025
NMTC NEUROONE MEDICAL TECHNOLOGIES ORD Common Shares 8.03% $2.8M 4M Bleichroeder LP Jun 30, 2025
GUER Guerrilla RF, Inc. Common Shares 7.73% $800K 800K Bleichroeder LP Mar 19, 2025
SMTK SmartKem, Inc. Common Shares 5.04% $171K -$75.2K 232K -30.5% Bleichroeder LP Jun 30, 2025
CMPO CompoSecure, Inc. Class A Common Stock, $0.0001 par value per share 4.7% $40.9M 3.9M Bleichroeder LP Sep 30, 2024
APTO Aptose Biosciences Inc. Common Shares 1.61% $4.58K -$13.4K 41.7K -74.4% Bleichroeder LP Jun 30, 2025

Schedules 13D/G Reported by Bleichroeder LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.